Showing results (611-620 of 765) with videos related to
Sort By:
Pageof 77
Toxicology Mechanisms and Methods|December 22, 2009
Energy and redox States in the c6 glioma cells following acute exposure to zn, se(+4), and se(+6) and the correlation with apoptosisM S Yang, W K F Tse, L C Yu, et al.Lung Cancer (Amsterdam, Netherlands)|June 13, 2013
Clinical significance of survivin and VEGF mRNA detection in the cell fraction of the peripheral blood in non-small cell lung cancer patients before and after surgeryX-P Tang, J Li, L-C Yu, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 14, 1999
CD1-restricted microbial lipid antigen-specific recognition found in the CD8+ alpha beta T cell poolJ P Rosat, E P Grant, E M Beckman, et al.Nature Immunology|April 5, 2012
Intrathymic programming of effector fates in three molecularly distinct γδ T cell subtypesKavitha Narayan, Katelyn E Sylvia, Nidhi Malhotra, et al.Nature Immunology|November 29, 2011
Invariant natural killer T cells direct B cell responses to cognate lipid antigen in an IL-21-dependent mannerIrah L King, Anne Fortier, Michael Tighe, et al.European Journal of Immunology|January 3, 2013
CD1d protein structure determines species-selective antigenicity of isoglobotrihexosylceramide (iGb3) to invariant NKT cellsJoseph P Sanderson, Patrick J Brennan, Salah Mansour, et al.The Journal of Experimental Medicine|May 11, 2011
Innate and cytokine-driven signals, rather than microbial antigens, dominate in natural killer T cell activation during microbial infectionManfred Brigl, Raju V V Tatituri, Gerald F M Watts, et al.Nature Immunology|November 1, 2011
Invariant natural killer T cells recognize lipid self antigen induced by microbial danger signalsPatrick J Brennan, Raju V V Tatituri, Manfred Brigl, et al.Science (New York, N.Y.)|June 13, 1997
Differential effects of cytolytic T cell subsets on intracellular infectionS Stenger, R J Mazzaccaro, K Uyemura, et al.British Journal of Pharmacology|June 18, 2025
Assessment of the molecular mechanisms of drug-induced hidden cardiotoxicity by a multi-omics approach: The example of rofecoxibBennet Y Weber, Gábor B Brenner, Barnabás Váradi, et al.Pageof 77